Announced Sun, 13 Sept, 2026 · 15:27 IST
Board comments on NSE and BSE fines for director appointment delay
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹2928.00
prior close
₹2930.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.2-0.5-0.8-3.9-0.8+0.7+0.3-0.3-1.4+7.7———
Up moveDown movePending
AI summary
Gland Pharma faced Rs 70,000 fines each from NSE and BSE for a 34-day technical breach of SEBI rule 17(1A) on appointing a director over 75 years old. Shareholders later approved the appointment on July 18, 2026. The company has paid both fines upfront and the board has asked management to strengthen compliance.
Likely market impact
Minor fines already paid. Procedural delay resolved with shareholder approval. No material impact on business or shareholders.